SCHEMBL7367528

SCHEMBL7367528

CCOc1cc(NC(C)=O)c(Cl)cc1C(=O)OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.59
ALDH1A1 P00352 9/20 0.55
HTT P42858 1/20 0.54
RORC P51449 1/20 0.51
HPGD P15428 7/20 0.51
POLB P06746 1/20 0.51
KDM4E B2RXH2 6/20 0.49
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
LMNA P02545 2/20 0.48
RAB9A P51151 2/20 0.48
AGER Q15109 1/20 0.48
NPY1R P25929 1/20 0.48
NPY2R P49146 1/20 0.48
HSD17B10 Q99714 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20099475 0.89 HTT (0.52) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL6229101 0.87 ALDH1A1 (0.56) TDP1ALDH1A1RORCHPGDKDM4E
SCHEMBL28758846 0.86 HTT (0.52) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL7370905 0.86 HTT (0.49) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL130152 0.85 HTT (0.72) ALDH1A1HTTHPGDPOLBKDM4E
SCHEMBL28733136 0.85 HTT (0.51) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL5321109 0.84 HTT (0.50) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL7414760 0.84 HTT (0.50) TDP1ALDH1A1HTTHPGDPOLB
SCHEMBL25658780 0.84 ALDH1A1 (0.61) TDP1ALDH1A1RORCHPGDKDM4E
SCHEMBL4503248 0.83 TDP1 (0.59) TDP1ALDH1A1HTTRORCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986199-A Synthesis method of mosapride citrate impurity 珠海润都制药股份有限公司 2024-05-07 CN claimed
CN-117986199-A Synthesis method of mosapride citrate impurity 珠海润都制药股份有限公司 2024-05-07 CN disclosed
CN-117986199-A Synthesis method of mosapride citrate impurity 珠海润都制药股份有限公司 2024-05-07 CN disclosed
EP-0243959-B1 SUBSTITUTED BENZAMIDE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Dainippon Pharmaceutical Co., Ltd. (JP) 1992-08-19 EP disclosed
US-4870074-A Substituted benzamide derivatives, for enhancing gastrointestinal motility DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1989-09-26 US disclosed
EP-0243959-A1 Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same Dainippon Pharmaceutical Co., Ltd. (JP) 1987-11-04 EP disclosed